Cargando…
New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients
Patients with cancer have a 6–7-fold higher risk of venous thromboembolism (VTE) as compared with non-cancer patients. Effective and safe anticoagulation for the prevention and treatment of VTE is the cornerstone of the management of patients with cancer, aiming to decrease morbidity and mortality a...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063799/ https://www.ncbi.nlm.nih.gov/pubmed/24966680 http://dx.doi.org/10.2147/TCRM.S49063 |